Should you require a reference on any vendor below, please contact Kristen Margeson at email@example.com
Gilmartin Group is a strategic advisory firm that provides comprehensive service offerings throughout the lifespan of our client companies. We have decades of experience in Capital Markets, Investor Relations, Corporate Communications and Business Development / Strategic Advisory services. Our professionals have spent their careers on Wall Street with backgrounds in Equity Research, Investment Banking and Equity Capital Markets. We bring that experience and expertise to our clients to create durable shareholder value.
For more information contact info@gilmartinIR.com
Kendall Investor Relations was founded to provide a truly different investor relations approach - we are former biotech senior executives with decades of experience in R&D, corporate development, commercial operations, finance, and investor relations, serving fellow biotech executives. We understand science, value creation, and how investors assess biotech investment opportunities. Our background, coupled with our relationships and credibility in the biotech investment community enables us to provide thoughtful, effective IR service that maximizes long term value.
LaVoieHealthScience provides strategic communications programs that integrate public and investor relations, marketing and communications to engage target stakeholders to create behavioral change. Our focus is on building value for health science innovations. Through our alliance with Omnicom Public Relations Group, we bring high-touch service with the global scale of 2,000 health expert consults across 100 countries.
We help our clients create awareness, gain recognition and optimal value for their initiatives, technologies, products and businesses. Our expert team of investor relations and public relations professionals design and execute communications programs that allow a client, product or initiative to reach its goals. We deliver a proven track record of designing and executing creative programs that effectively position and engage key stakeholders, with measurable return on investment.
Specializing in public health & wellness, biotech & pharma, medical technology and device markets, LaVoieHealthScience has a keen focus on strategic communications for the C-suite. We create and execute investor and public relations programs with a targeted market focus and/or a global point of view.
LaVoieHealthScience bring 18 years of industry-tested counsel, over 300 proven strategies for our clients, and differentiated communications programs to engage key stakeholders.
LifeSci Advisors is a unique investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach.
Our services are designed to increase our clients’ visibility within the investment community and to educate investors about the opportunity
Stern Investor Relations, Inc. is a NYC-based specialized investor relations (IR) firm focused on entrepreneurial health care and biotechnology companies. We work closely with our clients to implement strategic IR programs designed to effectively manage communications with the investment community.
Because we care. We genuinely want you to win, to succeed and to bring new and better medicines to the many people who deserve the right to live their best life possible.
We are not an agency, and not a vendor. Partnership is at the core of what we do, and that runs from the highest to the most tactical level.
Investor Relations that pulls from our extensive relations. Corporate Communications that starts and ends with your brand. Media Relations that serves an actionable purpose.
Westwicke Partners is the largest healthcare focused investor relations firm in the country. We provide customized investor relations programs and independent capital markets advice to small and mid-cap healthcare companies. Our background is unique in that our senior professionals all come directly from Wall Street as former sell-side research analysts, buy-side analysts and portfolio managers, investment bankers, institutional salespeople, traders and equity capital markets professionals.